
Katrina Thornber
Editorial Assistant at EMJ- European Medical Journal
Articles
-
21 hours ago |
emjreviews.com | Katrina Thornber
TREATMENT with intravascular brachytherapy (IVBT) for multilayer drug-eluting in-stent restenosis (DES-ISR) is associated with a lower rate of major adverse cardiac events (MACE) at three years compared to non-IVBT strategies. Multilayer in-stent restenosis (ISR), particularly in patients with multiple layers of drug-eluting stents, remains a significant clinical challenge due to high rates of recurrent adverse cardiac events.
-
1 day ago |
emjreviews.com | Katrina Thornber
NOVEL lymph-node-inspired hydrogels enhance CAR T cell activation and proliferation by 50%, offering a more efficient and cost-effective method for producing this cutting-edge cancer immunotherapy, according to a study published in ACS Applied Materials & Interfaces. CAR T cell therapy, which modifies a patient’s immune cells to target cancer, has revolutionised treatment for certain blood cancers but faces challenges in manufacturing efficiency and cost.
-
2 days ago |
emjreviews.com | Katrina Thornber
INTENSIVE blood pressure (BP) control in patients with hypertension reduces the risk of all-cause dementia by 15%, according to the CRHCP-3 cluster-randomised trial involving 33,995 individuals in rural China, published in Nature Medicine. Dementia, a leading global cause of disability and death, is projected to affect over 150 million people by 2050, with hypertension identified as a modifiable risk factor.
-
4 days ago |
emjreviews.com | Katrina Thornber
SELF-ADMINISTERED etripamil, an intranasal calcium channel blocker, significantly reduces emergency department (ED) visits for paroxysmal supraventricular tachycardia (PSVT) by 39% compared to placebo, according to a pooled analysis of the NODE-301 and RAPID randomised clinical trials involving 340 patients. PSVT, characterised by sudden rapid heart rates, often requires urgent medical intervention, with current oral therapies limited by delayed efficacy and safety concerns.
-
5 days ago |
emjreviews.com | Katrina Thornber
INDIVIDUALS with cognitive decline (dementia or mild cognitive impairment) carrying the APOE4 allele, experiencing early-onset dementia, or having Alzheimer’s disease, Parkinson’s disease, stroke, or severe cognitive impairment face a significantly higher risk of developing late-onset epilepsy (LOE), according to a longitudinal study of 14,685 participants across 39 US Alzheimer’s research centres.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →